Home » All » Stock Forecast » Akebia Therapeutics Inc. Common Stock Forecast

Akebia Therapeutics Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -1.40%Market Cap $377.74M · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$1.40 ▼ -0.88%	Yesterday	$1.42 ▲ +0.37%	Tomorrow's Akebia Therapeutics Inc. Common Stock (AKBA) setup is anchored to $1.41 and targets $1.40 (-0.88%). The near-term read is downside; watch $1.45 / $1.37 because daily realized volatility is about 4.56%.
Tomorrow's Akebia Therapeutics Inc. Common Stock (AKBA) setup is anchored to $1.41 and targets $1.40 (-0.88%). The near-term read is downside; watch $1.45 / $1.37 because daily realized volatility is about 4.56%.
Week	$1.37 ▼ -2.75%	Last Week	$1.43 ▲ +1.16%	The 7-day Akebia Therapeutics Inc. Common Stock model moves from $1.43 to $1.37 (-2.75%). It gives downside momentum context for this stock, so breaks around $1.45 / $1.37 matter more than a single tick.
The 7-day Akebia Therapeutics Inc. Common Stock model moves from $1.43 to $1.37 (-2.75%). It gives downside momentum context for this stock, so breaks around $1.45 / $1.37 matter more than a single tick.
Month	$1.33 ▼ -5.86%	Last Month	$1.44 ▲ +2.46%	The 1-month Akebia Therapeutics Inc. Common Stock target is $1.33 (-5.86%), compared with the live reference near $1.41. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Akebia Therapeutics Inc. Common Stock target is $1.33 (-5.86%), compared with the live reference near $1.41. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$1.26 ▼ -10.51%	Last Year	$1.47 ▲ +4.42%	The 1-year Akebia Therapeutics Inc. Common Stock scenario points to $1.26 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Akebia Therapeutics Inc. Common Stock scenario points to $1.26 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$1.11 ▼ -21.43%	5 Years Ago	$1.54 ▲ +9.00%	The 5-year Akebia Therapeutics Inc. Common Stock view is $1.11 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Akebia Therapeutics Inc. Common Stock view is $1.11 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$1.40▼ -0.88%

Yesterday$1.42▲ +0.37%

Tomorrow's Akebia Therapeutics Inc. Common Stock (AKBA) setup is anchored to $1.41 and targets $1.40 (-0.88%). The near-term read is downside; watch $1.45 / $1.37 because daily realized volatility is about 4.56%.

Week$1.37▼ -2.75%

Last Week$1.43▲ +1.16%

The 7-day Akebia Therapeutics Inc. Common Stock model moves from $1.43 to $1.37 (-2.75%). It gives downside momentum context for this stock, so breaks around $1.45 / $1.37 matter more than a single tick.

Month$1.33▼ -5.86%

Last Month$1.44▲ +2.46%

The 1-month Akebia Therapeutics Inc. Common Stock target is $1.33 (-5.86%), compared with the live reference near $1.41. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$1.26▼ -10.51%

Last Year$1.47▲ +4.42%

The 1-year Akebia Therapeutics Inc. Common Stock scenario points to $1.26 (-10.51%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$1.11▼ -21.43%

5 Years Ago$1.54▲ +9.00%

The 5-year Akebia Therapeutics Inc. Common Stock view is $1.11 (-21.43%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Bearish

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$1.41	Mid
Daily Change	-1.40%	Below
Volatility Cap	20.0%	Mid
Confidence	60%	Below
Data Source	nasdaq-screener	Mid

Historical Data

Current$1.41

Daily Change-1.40%

Market Cap$377.74M

Sourcenasdaq-screener

Current	$1.41	Daily Change	-1.40%
Market Cap	$377.74M	Source	nasdaq-screener

Support & Resistance Levels

$1.37Support 1

$1.41Current

$1.45Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$1.41Live reference price

Used as the anchor for generated forecast calculations.

Next Month$1.33Model projection-5.86%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

60%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

60%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in AKBA today

Bullish Scenario

$1.48

+5.00% from current

Target Price$1.48

ScenarioUpside momentum

Probability52%

Base Scenario

$1.33

-5.86%

Target Price$1.33

ScenarioCapped drift

Probability60%

Bearish Scenario

$1.34

-5.00% from current

Target Price$1.34

ScenarioVolatility drawdown

Probability40%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 38/100

24H drift-0.88%

7D drift-2.75%

30D drift-5.86%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 31/100

1M outlook-5.86%

1Y outlook-10.51%

5Y outlook-21.43%

Frequently Asked Questions

Q What is the Akebia Therapeutics Inc. Common Stock (AKBA) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Akebia Therapeutics Inc. Common Stock is projected near $1.40 versus the current reference around $1.41. That implies a modeled move of -0.88% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for AKBA?

The weekly Akebia Therapeutics Inc. Common Stock model points to $1.37, which maps to an expected drift of -2.75% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Akebia Therapeutics Inc. Common Stock 1-month and 1-year targets?

The Akebia Therapeutics Inc. Common Stock 1-month target is $1.33 (-5.86%), while the 1-year target is $1.26 (-10.51%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Akebia Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?

The Akebia Therapeutics Inc. Common Stock long-horizon scenario sits near $1.11 with a modeled change of -21.43%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are AKBA support and resistance zones right now?

For Akebia Therapeutics Inc. Common Stock, nearest resistance is around $1.37, while nearest support is around $1.45. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Akebia Therapeutics Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.